Why the Same Pill Works Differently in Different People: The Science of Personalized Medicine

At some point, nearly everyone has borrowed a recommendation from a trusted friend or family member — a specific cold remedy, a pain reliever, a sleep aid — only to find that the results were nothing like what was promised. The product was identical. The dosage was the same. Yet the experience was entirely different.

This is not coincidence, and it is not placebo effect working in reverse. It is biology, operating precisely as it is designed to.

The Body Is Not a Uniform Machine

When a medication enters the body, it embarks on a complex journey through absorption, distribution, metabolism, and elimination — a process pharmacologists refer to collectively as pharmacokinetics. Each stage of that journey is influenced by factors unique to the individual: genetics, age, body composition, liver function, kidney health, gut microbiome composition, and the presence of other medications or supplements in the system.

The result is that two people taking identical doses of the same drug may end up with dramatically different concentrations of that drug in their bloodstream at any given moment. One person may metabolize a medication so quickly that it exits the body before producing a meaningful effect. Another may process it so slowly that standard doses accumulate to levels that cause side effects.

This variability is not a flaw in pharmaceutical design. It is a reflection of the extraordinary diversity of human biology.

Pharmacogenomics: When Your Genes Rewrite the Instructions

The most well-documented driver of individual medication response is genetics. The field of pharmacogenomics — the study of how genes affect a person's response to drugs — has identified specific genetic variants that influence how efficiently the body processes hundreds of medications.

Central to this science are enzymes in the liver, particularly those belonging to the cytochrome P450 family. These enzymes are responsible for metabolizing a wide range of drugs, from common over-the-counter pain relievers to antidepressants and blood thinners. Genetic variations in the genes that encode these enzymes can render a person a "poor metabolizer," an "intermediate metabolizer," a "normal metabolizer," or, at the other extreme, an "ultrarapid metabolizer."

Consider codeine, a pain reliever that the body must convert into morphine to produce its intended effect. For ultrarapid metabolizers, this conversion happens so quickly and completely that even standard doses can produce dangerously elevated morphine levels. For poor metabolizers, the conversion barely occurs at all, leaving the medication largely ineffective. The same pill, the same dose, two entirely different biochemical outcomes.

While codeine is a prescription example, the underlying principle applies across many OTC categories. Certain antihistamines, for instance, are metabolized through similar enzymatic pathways, which helps explain why some individuals experience profound sedation while others feel almost nothing.

Beyond Genetics: The Other Variables That Matter

Genetics account for a significant portion of drug response variability, but they are far from the only factor worth understanding.

Age plays a meaningful role at both ends of the lifespan. Older adults often experience slower hepatic and renal clearance, meaning medications remain active in the body longer and at higher concentrations. Conversely, younger adults and adolescents may metabolize certain compounds more rapidly.

Body composition influences the distribution of fat-soluble versus water-soluble drugs throughout the body. A medication that distributes into fatty tissue will behave differently in individuals with varying body fat percentages, even when the same dose is administered.

Sex and hormonal status also contribute. Research has documented meaningful differences in drug absorption and metabolism between biological sexes, as well as changes that occur during pregnancy, menopause, or in individuals receiving hormone therapy.

The gut microbiome is an emerging area of research with significant implications. The trillions of microorganisms residing in the digestive tract can alter drug metabolism, influence how medications are absorbed, and even affect whether certain compounds are activated or deactivated before reaching systemic circulation.

Concurrent medications and supplements create another layer of complexity. Many common supplements — St. John's Wort being among the most studied — are known to induce or inhibit the same cytochrome P450 enzymes that process numerous prescription and OTC drugs. A supplement that seems entirely benign in isolation can meaningfully alter how a medication performs in the same body.

What This Means at the Pharmacy Counter

For most Americans, the pharmacy remains one of the most accessible points of contact with a healthcare professional. A licensed pharmacist possesses the clinical training to consider individual health profiles when helping customers navigate medication choices — yet many consumers approach the pharmacy as they would a grocery store, selecting products based on brand familiarity or a friend's recommendation without consulting the professional behind the counter.

This represents a missed opportunity.

When selecting an OTC product, particularly for recurring symptoms or for individuals managing chronic conditions, a brief conversation with a pharmacist can yield significantly more useful guidance than a product label alone. A pharmacist can account for current prescriptions, known allergies, relevant health history, and — increasingly — pharmacogenomic considerations if a patient has had genetic testing performed.

Some questions worth raising in that conversation include:

• "I've tried this product before and it didn't seem to work — could there be a reason for that?" This opens a dialogue about metabolism and absorption that a pharmacist is well-positioned to address.
• "I'm currently taking [medication or supplement] — are there any interactions I should be aware of?" A pharmacist can cross-reference your current regimen against any new product you are considering.
• "Are there formulations of this type of medication that work differently in the body?" Different delivery mechanisms — extended-release versus immediate-release, for example — can matter considerably depending on individual metabolism.

The Limits of Anecdotal Evidence

Perhaps the most practical takeaway from the science of pharmacogenomics and individual drug response is this: what works for someone else is data, but it is not your data.

A friend's enthusiastic endorsement of a particular pain reliever is genuinely useful information — it establishes that the product is capable of producing the desired effect in at least one person. But it says very little about how that product will behave in your body, given your genetic profile, your current medications, your liver function, and the dozens of other variables that make your biochemistry distinctly your own.

This is not an argument for pharmaceutical paralysis or excessive anxiety about every OTC purchase. Most people, most of the time, respond to common medications in reasonably predictable ways. The standard dosing guidelines printed on packaging are derived from large population studies precisely because they reflect the experience of the majority.

But when a medication consistently underperforms, when side effects appear that seem disproportionate to the dose, or when you are managing a complex health picture with multiple products or prescriptions, the science strongly supports a more individualized approach — one that begins not at the shelf, but at a conversation with a pharmacist who understands that your body has its own operating manual.